In the near-patient clinical lab, acute conditions like respiratory disease require immediate intervention. Correct identification of the causative pathogen is key to selecting the right treatment, but many respiratory pathogens cause similar symptoms. This makes it difficult for scientists to know which one they’re up against.
Multiplex syndromic testing rapidly and simultaneously surveys a large number of pathogens, giving users the answers they need when they need them.
Using direct swab or liquid transfer, the QIAstat-Dx provides results for 20+ respiratory or gastrointestinal pathogens in about 1 h, with less than 1 min of hands-on time. The TGA registered panels are available now in Australia.
For more information: https://qiastat-dx.com/row/are-you-ready-for-a-new-era-in-multiplex-syndromic-testing/.
Phone: 03 9840 9800
Bio-Rad Laboratories ddPLEX ESR1 Mutation Detection Kit
The kit enables simultaneous detection, discrimination and absolute quantification of seven known...
AdipoGen Life Sciences InVivoKines recombinant fusion proteins
InVivoKines are recombinant fusion proteins for immunotherapeutic, preclinical and translational...
EpigenTek MethylFlash 5-mC RNA Methylation ELISA Easy Kit (Fluorometric)
EpigenTek's MethylFlash 5-mC RNA Methylation ELISA Easy Kit (Fluorometric) is a complete set...
Learn More
I am interested in QIAGEN QIAstat-Dx syndromic testing instrument.
Complete the form and a supplier representative will be in touch.
